128 related articles for article (PubMed ID: 18185904)
1. Mycophenolate mofetil in the treatment of retroperitoneal fibrosis.
Khalil F; Mir MA; Venuto RC
Clin Rheumatol; 2008 May; 27(5):679-81. PubMed ID: 18185904
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mofetil for maintenance of remission in idiopathic retroperitoneal fibrosis.
Jois RN; Kerrigan N; Scott DG
Rheumatology (Oxford); 2007 Apr; 46(4):717-8. PubMed ID: 17218329
[No Abstract] [Full Text] [Related]
3. Treatment of retroperitoneal fibrosis by mycophenolate mofetil and corticosteroids.
Grotz W; von Zedtwitz I; Andre M; Schollmeyer P
Lancet; 1998 Oct; 352(9135):1195. PubMed ID: 9777843
[No Abstract] [Full Text] [Related]
4. Idiopathic retroperitoneal fibrosis: a role for mycophenolate mofetil.
Swartz RD; Lake AM; Roberts WW; Faerber GJ; Wolf JS
Clin Nephrol; 2008 Apr; 69(4):260-8. PubMed ID: 18397700
[TBL] [Abstract][Full Text] [Related]
5. Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis.
Scheel PJ; Piccini J; Rahman MH; Lawler L; Jarrett T
J Urol; 2007 Jul; 178(1):140-3; discussion 143-4. PubMed ID: 17499287
[TBL] [Abstract][Full Text] [Related]
6. Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis: a case series.
Scheel PJ; Feeley N; Sozio SM
Ann Intern Med; 2011 Jan; 154(1):31-6. PubMed ID: 21200036
[TBL] [Abstract][Full Text] [Related]
7. Successful mycophenolate mofetil therapy in nine patients with idiopathic retroperitoneal fibrosis.
Adler S; Lodermeyer S; Gaa J; Heemann U
Rheumatology (Oxford); 2008 Oct; 47(10):1535-8. PubMed ID: 18687710
[TBL] [Abstract][Full Text] [Related]
8. [Mycophenolate mofetil combined with steroids: new experiences in the treatment of idiopathic retroperitoneal fibrosis].
Obrencević K; Jovanović D; Kovacević Z; Hrvacević R; Ignjatović L; Mijusković M
Vojnosanit Pregl; 2007 Jun; 64(6):385-90. PubMed ID: 17687942
[TBL] [Abstract][Full Text] [Related]
9. Treatment of mediastinal fibrosis with mycophenolate mofetil.
Witschi M; Gugger M; Nicod LP
Respiration; 2009; 78(3):330-3. PubMed ID: 19295189
[TBL] [Abstract][Full Text] [Related]
10. The use of mycophenolate mofetil for the treatment of autoimmune and chronic idiopathic urticaria: experience in 19 patients.
Zimmerman AB; Berger EM; Elmariah SB; Soter NA
J Am Acad Dermatol; 2012 May; 66(5):767-70. PubMed ID: 21783274
[TBL] [Abstract][Full Text] [Related]
11. Medical management of retroperitoneal fibrosis.
Scheel PJ; Sozio SM; Feeley N
Trans Am Clin Climatol Assoc; 2012; 123():283-90; discussion 290-1. PubMed ID: 23303996
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic retroperitoneal fibrosis: a review of the pathogenesis and approaches to treatment.
Swartz RD
Am J Kidney Dis; 2009 Sep; 54(3):546-53. PubMed ID: 19515472
[TBL] [Abstract][Full Text] [Related]
13. Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent.
Megahed M; Schmiedeberg S; Becker J; Ruzicka T
J Am Acad Dermatol; 2001 Aug; 45(2):256-9. PubMed ID: 11464188
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment with mycophenolate mofetil of four Japanese patients with pemphigus vulgaris.
Koga H; Ishii N; Hamada T; Karashima T; Nakama T; Yasumoto S; Hashimoto T
Eur J Dermatol; 2010; 20(4):472-5. PubMed ID: 20406724
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil as therapy for pyoderma gangrenosum.
Eaton PA; Callen JP
Arch Dermatol; 2009 Jul; 145(7):781-5. PubMed ID: 19620559
[TBL] [Abstract][Full Text] [Related]
16. The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes.
Baven-Pronk AM; Coenraad MJ; van Buuren HR; de Man RA; van Erpecum KJ; Lamers MM; Drenth JP; van den Berg AP; Beuers UH; den Ouden J; Koek GH; van Nieuwkerk CM; Bouma G; Brouwer JT; van Hoek B
Aliment Pharmacol Ther; 2011 Aug; 34(3):335-43. PubMed ID: 21668459
[TBL] [Abstract][Full Text] [Related]
17. Standardized approach to idiopathic retroperitoneal fibrosis: a comprehensive review of the literature.
Roussel E; Callemeyn J; Van Moerkercke W
Acta Clin Belg; 2020 Aug; 75(4):239-244. PubMed ID: 31035909
[TBL] [Abstract][Full Text] [Related]
18. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.
Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Bonsmann G; Luger TA
Arch Dermatol; 2007 Dec; 143(12):1536-42. PubMed ID: 18087004
[TBL] [Abstract][Full Text] [Related]
19. [Mycophenolate mofetil--a new therapeutic agent for chronic autoimmune diseases].
Harboe E; Gøransson L; Wildhagen K; Omdal R
Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1650-2. PubMed ID: 15976831
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of mycophenolate mofetil in C3 glomerulonephritis.
Rabasco C; Cavero T; Román E; Rojas-Rivera J; Olea T; Espinosa M; Cabello V; Fernández-Juarez G; González F; Ávila A; Baltar JM; Díaz M; Alegre R; Elías S; Antón M; Frutos MA; Pobes A; Blasco M; Martín F; Bernis C; Macías M; Barroso S; de Lorenzo A; Ariceta G; López-Mendoza M; Rivas B; López-Revuelta K; Campistol JM; Mendizábal S; de Córdoba SR; Praga M;
Kidney Int; 2015 Nov; 88(5):1153-60. PubMed ID: 26221755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
